Hodgkin lymphoma
Jan 12, 2022
Insights into the Evolving Landscape of Antibody-Drug Conjugate (ADC) & the Key Companies in the Segment
In the year 2000, the first-ever Antibody-drug Conjugate (ADC) - Mylotarg, was launched by Pfizer and was considered a miracle in cancer treatment. And it appeared like there was no looking back for these antibody-drug conjugates. But it took almost another 11 years for the next ADC to launch in the market - Adectr...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
